These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6252175)

  • 1. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases.
    Young JP; Husson JM; Bruch K; Blomer RJ; Savopoulos C
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():293-300. PubMed ID: 6252175
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of severe systemic infections caused by multiple resistant organisms.
    Shah PM; Helm EB; Stille W
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():269-72. PubMed ID: 6252169
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftizoxime: clinical evaluation of efficacy and safety in the U.S.A.
    Parks D; Layne P; Uri J; Ziv D; Bass S
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():327-38. PubMed ID: 6296027
    [No Abstract]   [Full Text] [Related]  

  • 4. Cefotaxime in the treatment of severe paediatric infections.
    Papadatos CJ; Kafetzis DA; Kanarios J
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():243-8. PubMed ID: 6252164
    [No Abstract]   [Full Text] [Related]  

  • 5. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ceftriaxone in treatment of serious childhood infections.
    Chadwick EG; Connor EM; Shulman ST; Yogev R
    J Pediatr; 1983 Jul; 103(1):141-5. PubMed ID: 6306193
    [No Abstract]   [Full Text] [Related]  

  • 10. Cefotaxime in children: efficacy, tolerance and effect on the intestinal bacterial flora.
    Lambert-Zechovsky N; Aufrant C; Bingen E; Blum C; Proux MC; Mathieu H
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():235-42. PubMed ID: 6252163
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cefotaxime in infections caused by multi-resistant microorganisms].
    Aguirre M; Torres A; Alés JM
    Rev Clin Esp; 1981 Jan; 160(1):15-8. PubMed ID: 6259703
    [No Abstract]   [Full Text] [Related]  

  • 12. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children.
    McCracken GH; Nelson JD; Kaplan SL; Overturf GD; Rodriguez WJ; Steele RW
    Pediatr Infect Dis J; 1987 Jun; 6(6):501-5. PubMed ID: 3615064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rational parameters in the treatment of bacterial meningitis with modern cephalosporins].
    Brückner O; Trautmann M
    Infection; 1987; 15 Suppl 4():S214-9. PubMed ID: 3312038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial with cephapirin.
    Hodson AH; Holloway WJ
    Int J Clin Pharmacol; 1972 Apr; 6(1):10-2. PubMed ID: 4558782
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms.
    López EL; Bonesana NF; Rubeglio E; Schugurensky A; Sommersguter G; Grinstein S
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():249-53. PubMed ID: 6252165
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of cefotaxime in the management of pediatric infections.
    Jacobs RF
    Infection; 1991; 19 Suppl 6():S330-6. PubMed ID: 1791079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
    Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
    [No Abstract]   [Full Text] [Related]  

  • 18. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of Cephalosporins in childhood].
    Weippl G
    Wien Med Wochenschr Suppl; 1975; 27():23-6. PubMed ID: 1064251
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and bacteriologic experimentation with cephradine in pediatrics].
    Malherbe A
    Brux Med; 1974 Feb; 54(2):99-103. PubMed ID: 4434245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.